Flu Season Outlook- Severity, Cost and Point-of-Care Testing
What’s happening in Australia could spell bad news for Europe and the United States (U.S). This...
Trichomonas Rapid Point-of-Care Testing: Uncovering Diagnostic Options
What is Trichomonas?
Trichomoniasis is a common, curable, non-viral sexually transmitted...
Open Channel Clinical Chemistry Analyzers- Unleashing the Potential
Did you know you have the ability to unlock your instruments potential and add assays that are not...
Quantifying the Value of Diagnostics: An AdvaMedDx Overview
Diagnostics: The Value of Accurate, Timely Medical CareWhile the cost-driven healthcare industry...
European Commission Launches New Plan to Address Antimicrobial Resistance
The British In Vitro Diagnostics Association (BIVDA) recently highlighted attention in Europe on...
Clinical Chemistry: Why Pour Over?
In the field of clinical chemistry, most manufacture instruments are intended for use with the...
Helping Save Patient’s Lives: Diagnosing Sepsis
Sepsis was identified as the most expensive in-patient cost in U.S. hospitals in 2014, costing...
FDA Reclassifies Rapid Antigen Influenza Testing
On February 13, 2017, the FDA’s reclassification of rapid antigen influenza testing became...
Notes from EuroMedLab Athens 2017
Sekisui Diagnostics recently exhibited at the 22nd IFCC-EFLM European Congress of Clinical...
Vitamin D Point-of-Care Testing: Faster, Simpler & More Cost-Effective
While Vitamin D is typically recognized for boosting tooth and bone health and warding off...